Innovative Lupus Therapies Unequally Accessible in Serbia

Innovative therapies and medications for lupus are not equally accessible to all patients in Serbia, despite the possibility of reimbursement from the RFZO, due to administrative barriers and inconsistent practices in healthcare institutions.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

danasCroatian2d ago

Inovativne terapije i lekovi za lupus nisu jednako dostupni svim pacijentima

Inovativne terapije i lekovi za lupus nisu jednako dostupni svim pacijentima u Srbiji, iako troškovi mogu biti refundirani od strane RFZO-a. Razlog su administrativne prepreke i neujednačena praksa u zdravstvenim ustanovama, rečeno je danas na skupu na kome se govorilo o izazovima u lečenju i značaju savremenih terapija za obolele u Srbiji.

Read full article →

PERSPECTA

PERSPECTA

Innovative Lupus Therapies Unequally Accessible in Serbia

Sources

Inovativne terapije i lekovi za lupus nisu jednako dostupni svim pacijentima

Related Stories

Trump Considers Military Action Against Iran Amid Hormuz Blockade Discussions; UK Declines to Join

Alex Batty to Share Story After Vanishing at Age 11

Philippine House Approves Impeachment Articles Against VP Sara Duterte

Philippine House Approves Impeachment Articles Against VP Duterte

PERSPECTA